China National Medicines Corporation Ltd. (SHA:600511)
China
· Delayed Price · Currency is CNY 28.73
-0.03 (-0.10%)
Apr 29, 2026, 3:00 PM CST
SHA:600511 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 7,811 | 11,482 | 10,886 | 10,926 | 8,896 | 7,304 | Upgrade
|
| Trading Asset Securities | - | - | - | - | - | 11.4 | Upgrade
|
| Cash & Short-Term Investments | 7,811 | 11,482 | 10,886 | 10,926 | 8,896 | 7,316 | Upgrade
|
| Cash Growth | -11.72% | 5.47% | -0.36% | 22.81% | 21.60% | 17.53% | Upgrade
|
| Accounts Receivable | 17,724 | 14,743 | 13,931 | 12,881 | 12,550 | 13,392 | Upgrade
|
| Other Receivables | 384.21 | 186.45 | 199.01 | 204 | 389.69 | 79.93 | Upgrade
|
| Receivables | 18,108 | 14,929 | 14,130 | 13,085 | 12,940 | 13,472 | Upgrade
|
| Inventory | 5,183 | 5,192 | 4,956 | 3,961 | 3,717 | 3,515 | Upgrade
|
| Other Current Assets | 209.87 | 388.21 | 385.73 | 307.79 | 210.44 | 280.62 | Upgrade
|
| Total Current Assets | 31,311 | 31,991 | 30,357 | 28,279 | 25,764 | 24,584 | Upgrade
|
| Property, Plant & Equipment | 782.13 | 778.96 | 878.6 | 827.04 | 857.91 | 845.06 | Upgrade
|
| Long-Term Investments | 2,646 | 2,465 | 2,176 | 1,907 | 1,623 | 1,365 | Upgrade
|
| Goodwill | 203.77 | 203.77 | 203.77 | 203.77 | 203.77 | 203.77 | Upgrade
|
| Other Intangible Assets | 236.13 | 243.1 | 276.76 | 258.11 | 262.92 | 258.65 | Upgrade
|
| Long-Term Deferred Tax Assets | 162.22 | 163.25 | 149.07 | 123.87 | 124.37 | 115.94 | Upgrade
|
| Long-Term Deferred Charges | 143.81 | 148.78 | 152.39 | 150.06 | 86.19 | 89.6 | Upgrade
|
| Other Long-Term Assets | 690.56 | 690.6 | 734.85 | 703.57 | 686.95 | 548.08 | Upgrade
|
| Total Assets | 36,176 | 36,685 | 34,928 | 32,453 | 29,609 | 28,010 | Upgrade
|
| Accounts Payable | 12,244 | 12,785 | 12,086 | 10,943 | 9,917 | 10,058 | Upgrade
|
| Accrued Expenses | 104.56 | 498.67 | 536.83 | 604.96 | 640.01 | 564.03 | Upgrade
|
| Short-Term Debt | 196.57 | 222.31 | 485.06 | 268.35 | 252.06 | 428.83 | Upgrade
|
| Current Portion of Leases | - | 102.11 | 100.2 | 74.08 | 80.5 | 75.81 | Upgrade
|
| Current Income Taxes Payable | 94.32 | 46.54 | 87.49 | 113.17 | 84.89 | 112.18 | Upgrade
|
| Current Unearned Revenue | 66.79 | 67.88 | 275.25 | 61.12 | 176.9 | 43.68 | Upgrade
|
| Other Current Liabilities | 1,553 | 1,680 | 1,285 | 1,830 | 1,589 | 1,457 | Upgrade
|
| Total Current Liabilities | 14,355 | 15,402 | 14,856 | 13,894 | 12,740 | 12,739 | Upgrade
|
| Long-Term Leases | 214.57 | 191.86 | 260.69 | 205.08 | 182.57 | 197.29 | Upgrade
|
| Long-Term Unearned Revenue | 32.55 | 34.18 | 38.79 | 46.06 | 46.35 | 42.66 | Upgrade
|
| Pension & Post-Retirement Benefits | - | 0.19 | 0.27 | 0.44 | 0.45 | 0.54 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 16.7 | 17.8 | 24.19 | 26.78 | 33.47 | 35.39 | Upgrade
|
| Other Long-Term Liabilities | 730.82 | 730.63 | 773.55 | 747.14 | 747.14 | 639.8 | Upgrade
|
| Total Liabilities | 15,349 | 16,377 | 15,953 | 14,920 | 13,750 | 13,655 | Upgrade
|
| Common Stock | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | Upgrade
|
| Additional Paid-In Capital | 2,349 | 2,349 | 2,349 | 2,349 | 2,349 | 2,349 | Upgrade
|
| Retained Earnings | 15,865 | 15,390 | 13,997 | 12,642 | 11,087 | 9,652 | Upgrade
|
| Comprehensive Income & Other | 78.07 | 50.92 | 27.28 | 30.74 | 24.04 | 24.91 | Upgrade
|
| Total Common Equity | 19,046 | 18,545 | 17,128 | 15,776 | 14,215 | 12,780 | Upgrade
|
| Minority Interest | 1,781 | 1,764 | 1,847 | 1,757 | 1,645 | 1,575 | Upgrade
|
| Shareholders' Equity | 20,827 | 20,308 | 18,975 | 17,533 | 15,859 | 14,355 | Upgrade
|
| Total Liabilities & Equity | 36,176 | 36,685 | 34,928 | 32,453 | 29,609 | 28,010 | Upgrade
|
| Total Debt | 506.36 | 516.28 | 845.95 | 547.5 | 515.13 | 701.93 | Upgrade
|
| Net Cash (Debt) | 7,304 | 10,965 | 10,040 | 10,378 | 8,381 | 6,614 | Upgrade
|
| Net Cash Growth | -8.57% | 9.22% | -3.26% | 23.83% | 26.72% | 21.97% | Upgrade
|
| Net Cash Per Share | 9.68 | 14.53 | 13.31 | 13.76 | 11.11 | 8.77 | Upgrade
|
| Filing Date Shares Outstanding | 754.48 | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | Upgrade
|
| Total Common Shares Outstanding | 754.48 | 754.5 | 754.5 | 754.5 | 754.5 | 754.5 | Upgrade
|
| Working Capital | 16,957 | 16,589 | 15,501 | 14,385 | 13,025 | 11,845 | Upgrade
|
| Book Value Per Share | 25.24 | 24.58 | 22.70 | 20.91 | 18.84 | 16.94 | Upgrade
|
| Tangible Book Value | 18,606 | 18,098 | 16,648 | 15,314 | 13,748 | 12,318 | Upgrade
|
| Tangible Book Value Per Share | 24.66 | 23.99 | 22.06 | 20.30 | 18.22 | 16.33 | Upgrade
|
| Buildings | - | 408.84 | 408.84 | 408.84 | 433.49 | 387.18 | Upgrade
|
| Machinery | - | 830.63 | 802.66 | 759.8 | 702.78 | 661.15 | Upgrade
|
| Construction In Progress | - | - | 0.57 | 2.54 | 36.21 | 57.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.